1. The world's now scrambling for dry ice. It's just one headache in getting coronavirus vaccines where they need to go  CNN
  2. Sinovac Biotech's COVID-19 vaccine candidate triggers immune response  News-Medical.Net
  3. China Sinopharm's COVID-19 vaccine taken by about a million people in emergency use  CGTN
  4. Sinovac may get Phase III trial results of COVID-19 vaccine by December, executive says  The Star Online
  5. Chinese pharmaceutical giant Sinopharm claims it has already vaccinated one million against coronavirus in China  7NEWS.com.au
  6. View Full Coverage on Google News

There are currently 11 COVID vaccines in large-scale phase three trials. Here is everything you need to know about them.There are currently 11 COVID vaccines in large-scale phase three trials. Here is everything you need to know about them.

The 11 vaccines closest to be being ready for the public

Now, Sinovac Biotech's candidate vaccine, CoronaVac, has been found to induce an immune response in healthy adults aged 18–59 years, 28 days post-vaccination. However, the level of antibodies generated was lower than in people who had recovered from the illness.Now, Sinovac Biotech's candidate vaccine, CoronaVac, has been found to induce an immune response in healthy adults aged 18–59 years, 28 days post-vaccination. However, the level of antibodies generated was lower than in people who had recovered from the illness.

Sinovac Biotech's COVID-19 vaccine candidate triggers immune response

This article fouses on a Chinese Covid-19 vaccine which has shown good results in the intital clinical trial phase. Know all the details.This article fouses on a Chinese Covid-19 vaccine which has shown good results in the intital clinical trial phase. Know all the details.

Covid-19 Vaccine from Beijing Appears Safe, Initial Shows Good Response

Five Chinese vaccines undergo phase-III clinical trials overseas - CGTN

Turkey will sign a contract within days to buy at least 20 million doses of a COVID-19 candidate vaccine from China's Sinovac Biotech, the health minister was cited as saying, adding that Ankara was also in talks to buy doses of Pfizer and BioNTech's vaccine. Turkey would become the second buyer of the Chinese vaccine after Brazil.Turkey will sign a contract within days to buy at least 20 million doses of a COVID-19 candidate vaccine from China's Sinovac Biotech, the health minister was cited as saying, adding that Ankara was also in talks to buy doses of Pfizer and BioNTech's vaccine. Turkey would become the second buyer of the Chinese vaccine after Brazil.

Turkey to buy Chinese COVID-19 candidate vaccine doses, in talks with Pfizer

Health Minister Fahrettin Koca said the country planned to procure at least 10 million doses of the candidate vaccine in December.Health Minister Fahrettin Koca said the country planned to procure at least 10 million doses of the candidate vaccine in December.

Covid vaccine: Turkey to buy at least 20 million doses of Chinese candidate | The Independent

Bloomberg - Are you a robot?

Nearly a million people have taken an experimental coronavirus vaccine developed by Chinese company Sinopharm, the firm said, although it has not yetNearly a million people have taken an experimental coronavirus vaccine developed by Chinese company Sinopharm, the firm said, although it has not yet provided any clear clinical evidence of efficac…

China says almost 1 million have had vaccine: firm - Asia Times

Beijing: Five Chinese Covid-19 vaccine candidates are in Phase III clinical trials in foreign countries including the United Arab Emirates, Brazil, Pakistan and Peru, Foreign Ministry spokesman Zhao Lijian said.Beijing: Five Chinese Covid-19 vaccine candidates are in Phase III clinical trials in foreign countries including the United Arab Emirates, Brazil, Pakistan and Peru, Foreign Ministry spokesman Zhao Lijian said.

Five Chinese Covid-19 vaccines undergo clinical trials | The Star

Brazil authorities have recieved the first 120,000 doses of CoronaVac, a COVID-19 vaccine developed by China's Sinovac Biotech. that is being tested in Brazil. The vaccine is still being tested and will not be distributed yet. Final Phase 3 trials to assess the efficacy and safety of the vaccine are still ongoing in...Brazil authorities have recieved the first 120,000 doses of CoronaVac, a COVID-19 vaccine developed by China's Sinovac Biotech. that is being tested in Brazil....

First doses of China's COVID-19 vaccine arrives in Brazil | SBS News

The first 120,000 doses of CoronaVac, a COVID-19 vaccine developed by China's Sinovac Biotech that is being tested in Brazil, arrived at São Paulo's international airport on Thursday morning, the state government said. The doses will be stored in an undisclosed warehouse as the state awaits approval for use in…The first 120,000 doses of CoronaVac, a COVID-19 vaccine developed by China's Sinovac Biotech that is being tested in Brazil, arrived at São Paulo's international airport on Thursday morning, the state government said. The doses will be stored in an undisclosed warehouse as the state awaits approval for use in…

First doses of China's CoronaVac Covid-19 vaccine arrive in Brazil | Cyprus Mail

Beijing, China, Nov 20 - Nearly a million people have taken an experimental coronavirus vaccine developed by Chinese company Sinopharm, the firm said, - Kenya breaking news | Kenya news today | Capitalfm.co.keBeijing, China, Nov 20 – Nearly a million people have taken an experimental coronavirus vaccine developed by Chinese company Sinopharm, the firm said, although it has not yet provided any clear clinical evidence of efficacy. China has been giving experimental Covid-19 vaccines to people including state employees, international students and essential workers heading abroad since […]

Almost a million people inoculated with Chinese Covid-19 vaccine: firm » Capital News

There are over 50 clinical trials worldwide, testing potential vaccines, known as candidates, against COVID-19. None of the vaccine candidates have been approved.There are over 50 clinical trials worldwide, testing potential vaccines, known as candidates, against COVID-19. None of the vaccine candidates have been approved.

When will we have a COVID-19 vaccine? - Times of Oman

Turkey is holding talks for the procurement of a potential vaccine developed by Pfizer and its German partner BioNTech, the country’s health minister has said.Turkey is holding talks for the procurement of a potential vaccine developed by Pfizer and its German partner BioNTech, the country’s health minister has said.

Turkey in talks for Pfizer’s COVID-19 vaccine - Turkey News

Turkey in talks with Pfizer for 25 million doses of coronavirus vaccine: Health Minister KocaTurkey is in talks with Pfizer for a million doses of the coronavirus vaccine by year-end and 25 million more in 2021, Health Minister Fahrettin Koca said in a statement late...

Turkey in talks with Pfizer for 25 million doses of coronavirus vaccine: Health Minister Koca | Daily Sabah

A study suggests that one of China's vaccines shows a quick immune response.A study suggests that one of China's vaccines shows a quick immune response.

sign-in

A Covid-19 vaccine developed in China has shown success in mid-stage trials, researchers say. There are several vaccines being developed in China, some of which are already being administered.

Covid-19: Chinese Vaccine "Successful in Mid-stage Trials" - Novinite.com - Sofia News Agency

CORONAVIRUS vaccine update: A new experimental vaccine developed in China triggered a quick immune response, preliminary trial results showed today. How promising is the vaccine and how does it fare against other promising candidates? CORONAVIRUS vaccine update: A new experimental vaccine developed in China triggered a quick immune response, preliminary trial results showed today. How promising is the vaccine and how does it fare against other promising candidates?

Coronavirus latest vaccine update: CoronaVac stimulates quick immune response to symptoms | Express.co.uk

SINGAPORE/BEIJING (Reuters) - Sinovac Biotech’s experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.SINGAPORE/BEIJING (Reuters) - Sinovac Biotech’s experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.

Sinovac's COVID-19 vaccine induces quick immune response: study - Egypt Independent

Early-phase trials for China's latest vaccine have proven "safe" and produced antibody responses in volunteers aged 18 to 59 years, a major study revealed on Tuesday.Early-phase trials for China's latest vaccine have proven "safe" and produced antibody responses in volunteers aged 18 to 59 years, a major study revealed on Tuesday.

China's CoronaVac Triggers Rapid Immune Response In Preliminary Volunteer Trials, Lancet Study Finds - Sputnik International

Sinovac Biotech is conducting phase three trials in Indonesia, Brazil and Turkey. Unlike Pfizer-BioNtech and Moderna vaccines, its vaccine can be stored at a temperature between 2 and 8 degrees Celsius in any refrigerator at home and is stable for up to three years. A government campaign is trying to overcome the effect of past vaccine scandals.   Sinovac Biotech is conducting phase three trials in Indonesia, Brazil and Turkey. Unlike Pfizer-BioNtech and Moderna vaccines, its vaccine can be stored at a temperature between 2 and 8 degrees Celsius in any refrigerator at home and is stable for up to three years. A government campaign is trying to overcome the effect of past vaccine scandals.  

CHINA Chinese experimental vaccine induces a quick response

A week after one of its tests in Brazil was stopped amid a safety scare, Chinese biotech Sinovac has published data showing its experimental COVID-19 vaccine can quickly boost an immune response.A week after one of its tests in Brazil was stopped amid a safety scare, Chinese biotech Sinovac has published data showing its experimental COVID-19 vaccine can quickly boost an immune response.

China's Sinovac sees speedy immune response with COVID-19 shot in early trials | FierceBiotech

Results from an early-phase randomised clinical trial of a Chinese vaccine candidate based on the inactivated whole SARS-CoV-2 virus (CoronaVac) are published today in The Lancet Infectious Diseases journal, ...

Chinese COVID vaccine candidate based on inactivated virus appears safe, induces immune response, study finds

A study found the vaccine candidate produced a quick immune response but lower levels of antibodies than in recovered coronavirus patients.A study found the vaccine candidate produced a quick immune response but lower levels of antibodies than in recovered coronavirus patients.

Coronavirus vaccine: China's Sinovac reports mixed findings in early clinical trials - The Washington Post

Hundreds of thousands of people in China have already received this vaccine. Now, preliminary trials are showing promising results, although it's too early to say whether it can prevent disease.Hundreds of thousands of people in China have already received this vaccine. Now, preliminary trials are showing promising results, although it's too early to say whether it can prevent disease.

Early Trials Of Sinovac's Vaccine Show It Triggers An Immune Response : Coronavirus Updates : NPR

BEIJING/NEW YORK • Sinovac Biotech's experimental Covid-19 vaccine triggered a quick immune response, but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed yesterday.. Read more at straitstimes.com.East Asia News -BEIJING/NEW YORK • Sinovac Biotech's experimental Covid-19 vaccine triggered a quick immune response, but the level of antibodies produced was lower than in people who had recovered

Early trials show promise for Sinovac vaccine, East Asia News & Top Stories - The Straits Times

NoCookies | The Australian

Although the results are positive the process still requires further testing. The CoronaVac by Sinovac Biotech still needs to go through the third phase of testing.

COVID-19 Vaccine: Positive test results from China - Newsbook

Preliminary results show CoronaVac triggered a quick immune response but level of antibodies were lower than in people who had recovered from the disease.Preliminary results show CoronaVac triggered a quick immune response but level of antibodies were lower than in people who had recovered from the disease.

China’s Sinovac coronavirus vaccine induces quick immune response: study - National | Globalnews.ca

Results from an early-phase randomised clinical trial of the Chinese Covid-19 vaccine candidate CoronaVac show that the formulation appears safe and induces an antibody response in...Results from an early-phase randomised clinical trial of the Chinese Covid-19 vaccine candidate CoronaVac show that the formulation appears safe and induces an antibody response in...

China’s Covid vaccine appears safe, causes immune response - world news - Hindustan Times

Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in peoSinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in peo

Sinovac's COVID-19 vaccine induces quick immune response - study - Times of India

Chinese COVID-19 vaccine candidate appears safe, induces immune response, preliminary study finds Greater Kashmir | Results from an early-phase clinical trial of a Chinese vaccine candidate, CoronaVac, revealed that the formulation appears safe and induces an antibodyChinese COVID-19 vaccine candidate appears safe, induces immune response, preliminary study finds Greater Kashmir | Results from an early-phase clinical trial of a Chinese vaccine candidate, CoronaVac, revealed that the formulation appears safe and induces an antibody

Chinese COVID-19 vaccine candidate appears safe, induces immune response, preliminary study finds | Greater Kashmir

The first 120,000 doses of CoronaVac, a COVID-19 vaccine developed by China's Sinovac Biotech <SVA.O> that is being tested in Brazil, arrived at São Paulo's international airport on Thursday morning, the state government said.The first 120,000 doses of CoronaVac, a COVID-19 vaccine developed by China's Sinovac Biotech <SVA.O> that is being tested in Brazil, arrived at São Paulo's international airport on Thursday morning, the state government said.

First doses of China's CoronaVac COVID-19 vaccine arrive in Brazil | Reuters

Sinovac's COVID-19 vaccine induces quick immune responseSinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.

Sinovac's COVID-19 vaccine induces quick immune response | bdnews24.com

Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.

Sinovac's COVID-19 vaccine induces quick immune response

Sinovac's CoronaVac is in large late-stage trials in Brazil, Indonesia and Turkey.The results follow news this month from Pfizer Inc and BioNTech and from Moderna, as well as from Russia, of experimental vaccines proving more than 90% effectiveSinovac's CoronaVac is in large late-stage trials in Brazil, Indonesia and Turkey.The results follow news this month from Pfizer Inc and BioNTech and from Moderna, as well as from Russia, of experimental vaccines proving more than 90% effective

Covid vaccine: China's Sinovac may get Phase III trial results next month

Sinovac Biotech’s experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.Sinovac Biotech’s experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.

Sinovac's COVID-19 vaccine induces quick immune response: study - Citizentv.co.ke

A Covid-19 vaccine developed in China has shown success in mid-stage trials, researchers say.A Covid-19 vaccine developed in China has shown success in mid-stage trials, researchers say.

Chinese Covid-19 vaccine 'successful in mid-stage trials' | Loop PNG

Chinese vaccine 'successful in mid-stage trials' A COVID-19 vaccine developed in China has shown success in mid-stage trials. There are several vaccines being developed in China, some of which are a

Chinese vaccine 'successful in mid-stage trials'

Sucuri WebSite Firewall - Access Denied